20146-25-2 Usage
General Description
2-(2-FURYL)-4-QUINOLINECARBOXYLIC ACID is an organic compound belonging to the quinoline carboxylic acid family. It is a derivative of quinoline and furan, containing a furan ring fused with a quinoline ring and a carboxylic acid group. This chemical is commonly used in the pharmaceutical industry as a building block for the synthesis of various drugs, especially those with antimicrobial and anti-inflammatory properties. 2-(2-FURYL)-4-QUINOLINECARBOXYLIC ACID is also being studied for its potential applications in organic electronics and material science.
Check Digit Verification of cas no
The CAS Registry Mumber 20146-25-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,1,4 and 6 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 20146-25:
(7*2)+(6*0)+(5*1)+(4*4)+(3*6)+(2*2)+(1*5)=62
62 % 10 = 2
So 20146-25-2 is a valid CAS Registry Number.
InChI:InChI=1/C14H9NO3/c16-14(17)10-8-12(13-6-3-7-18-13)15-11-5-2-1-4-9(10)11/h1-8H,(H,16,17)
20146-25-2Relevant articles and documents
Nitrofuryl heterocycles. 8. 2-(5-Nitro-2-furyl)cinchoninic acid derivatives.
Burch
, p. 535 - 538 (1969)
-
2-furanyl-quinoline-4-formamide compound and application thereof
-
Paragraph 0018-0020; 0033-0035, (2021/02/06)
The invention discloses a 2-furanyl-quinoline-4-formamide compound and application thereof, and the structural formula of the 2-furanyl-quinoline-4-formamide compound is shown as a formula (4) in thespecification, wherein R1 is selected from H, halogen or
Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity
Chen, Xiuli,Sun, Weining,Huang, Shenzhen,Zhang, Hailin,Lin, Guifeng,Li, Hui,Qiao, Jingxin,Li, Linli,Yang, Shengyong
, p. 10474 - 10495 (2020/11/02)
SIRT6 activation is thought to be a promising target for the treatment of many diseases, particularly cancer. Herein, we report the discovery of a series of new small-molecule SIRT6 activators. Structure-activity relationship analyses led to the identific